Article

IVI Research Brief Uses Patient Insights as Foundation for Value

A research brief from the Innovation and Value Initiative (IVI) sought to determine how metastatic non-small lung cancer patients’ perspectives and experiences shape cancer-related treatment decisions.

A research brief from the Innovation and Value Initiative (IVI) sought to determine how metastatic non-small lung cancer (NSCLC) patients’ perspectives and experiences shape cancer-related treatment decisions. IVI constructed in-depth interviews and focus groups with patients with metastatic NSCLC to gain insight into their perspectives on disease burden and treatment.

The research brief identified several broad themes including the need to make frequent trade-offs in treatment decisions and urgency created by the metastatic nature of disease. Patients also identified specific determinants of value in their treatment experience, including personalized care and treatments that offer tolerable side effects.

Read the full research brief.

Related Videos
Nini Wu, MD, Navista
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Dr Margrit Wiesendanger
Tom Belmon, CAP, GPBCH
Tom Belmont
Natalie Bedford sitting for a video interview
AJMC background with headshots for Joe DePinto, MBA; Kathi Henson, MBA; and Natalie Bedford | Background image credit: ipopba - stock.adobe.com
Lalan Wilfong, MD
Dr Kimlin Tam Ashing
Nini Wu, MD, MBA
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo